Our work demonstrates that hyper-acetylated mitochondrial proteins are hallmarks of both sporadic and familial ALS and elevating SIRT3 activity can be explored as a therapeutic strategy for ALS. This evidence concerns the gene SIRT3 and amyotrophic lateral sclerosis.